BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 2, 2003, Pages 90-95

  Ginolhac, Sophie M ^a,b   Gad, Sophie ^a   Corbex, Marilys ^b   Bressac de Paillerets, Brigitte ^d   Chompret, Agnès ^d   Bignon, Yves Jean ^e   Peyrat, Jean Philippe ^f   Fournier, Joelle ^f   Lasset, Christine ^g   Giraud, Sophie ^h   Muller, Danièle ⁱ   Fricker, Jean Pierre ⁱ   Hardouin, Agnès ^j   Berthet, Pascaline ^j   Maugard, Christine ^k   Nogues, Catherine ^l   Lidereau, Rosette ^l   Longy, Michel ^m   Olschwang, Sylviane ⁿ   Toulas, Christine ^o   Guimbaud, Rosine ^o   Yannoukakos, Drakoulis ^p   Szabo, Csilla ^b   Durocher, Francine ^q,r   Moisan, Anne Marie ^q,r   Simard, Jacques ^q,r   Mazoyer, Sylvie ^a   Lynch, Henry T ^s   Goldgar, David ^b   Stoppa Lyonnet, Dominique ^c   Lenoir, Gilbert M ^b,d   Sinilnikova, Olga M ^b,h   more..

^a CNRS   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c INSTITUT CURIE   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e CENTRE JEAN PERRIN   (France)

^f CENTRE OSCAR LAMBRET   (France)

^g CENTRE LÉON BÉRARD   (France)

^h HOSPICES CIVILS DE LYON   (France)

ⁱ CENTRE PAUL STRAUSS   (France)

^j CENTRE FRANÇOIS BACLESSE   (France)

^k CENTRE RENÉ GAUDUCHEAU   (France)

^l CENTRE RENÉ HUGUENIN   (France)

^m INSTITUT BERGONIÉ   (France)

ⁿ Ctr d'Etud du Polymorphisme Humain 27 Rue Juliette Dodu 75010   (France)

^o INSTITUT CLAUDIUS REGAUD   (France)

^p INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^q LAVAL UNIVERSITY   (Canada)

^r INHERIT BRCAs   (United States)

^s CREIGHTON UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BRCA1 PROTEIN; GENE PRODUCT; GLUTAMIC ACID; GLYCINE; SERINE;

ADULT; ALLELISM; ARTICLE; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CORRELATION ANALYSIS; DNA STRAND BREAKAGE; FAMILIAL CANCER; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; GERM LINE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PENETRANCE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; ALLELES; BREAST NEOPLASMS; CANADA; FEMALE; FOLLOW-UP STUDIES; FRANCE; GENE FREQUENCY; GENES, BRCA1; GENETIC MARKERS; GERM-LINE MUTATION; GREECE; HETEROZYGOTE; HUMANS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; OVARIAN NEOPLASMS; PARITY; POLYMORPHISM, GENETIC; RISK FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 12244289250     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Easton, D. F., Ford, D., and Bishop, D. T. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am. J. Hum. Genet., 56: 265-271, 1995.
2. Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., Sobol, H., Teare, M. D., Struewing, J., Arason, A., Scherneck, S., Peto, J., Rebbeck, T. R., Tonin, P., Neuhausen, S., Barkardottir, R., Eyfjord, J., Lynch, H., Ponder, B. A., Gayther, S. A., Birch, J. M., Lindblom, A., Stoppa-Lyonnet, D., Bignon, Y. J., Borg, Å., Hamann, U., Haites, N., Scott, R. J., Maugard, C. M., Vasen, H., Seitz, S., Cannon-Albright, L. A., Schofield, A., Zelada-Hedman, M., and the Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet., 62: 676-689, 1998.
3. Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., and Tucker, M. A. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med., 336: 1401-1408, 1997.
4. Fodor, F. H., Weston, A., Bleiweiss, I. J., McCurdy, L. D., Walsh, M. M., Tartter, P. I., Brower, S. T., and Eng, C. M. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am. J. Hum. Genet., 63: 45-51, 1998.
5. Hopper, J. L., Southey, M. C., Dite, G. S., Jolley, D. J., Giles, G. G., McCredie, M. R., Easton, D. F., and Venter, D. J. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol. Biomark. Prev., 8: 741-747, 1999.
6. Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br. J. Cancer, 83: 1301-1308, 2000.
7. Narod, S. Modifiers of risk of hereditary breast and ovarian cancer. Nat. Rev Cancer, 2: 113-123, 2002.
8. Narod, S. A., Goldgar, D., Cannon-Albright, L., Weber, B., Moslehi, R., Ives, E., Lenoir, G., and Lynch, H. Risk modifiers in carriers of BRCA1 mutations. Int. J. Cancer, 64: 394-398, 1995.
9. Jernstrom, H., Lerman, C., Ghadirian, P., Lynch, H. T., Weber, B., Garber, J., Daly, M., Olopade, O. I., Foulkes, W. D., Warner, E., Brunet, J. S., and Narod, S. A. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet, 354: 1846-1850, 1999.
10. Rebbeck, T. R., Levin, A. M., Eisen, A., Snyder, C., Watson, P., Cannon-Albright, L., Isaacs, C., Olopade, O., Garber, J. E., Godwin, A. K., Daly, M. B., Narod, S. A., Neuhausen, S. L., Lynch, H. T., and Weber, B. L. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J. Natl. Cancer Inst. (Bethesda), 91: 1475-1479, 1999.
11. Narod, S. A., Risch, H., Moslehi, R., Dorum, A., Neuhausen, S., Olsson, H., Provencher, D., Radice, P., Evans, G., Bishop, S., Brunet, J. S., and Ponder, B. A. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N. Engl. J. Med., 339: 424-428, 1998.
12. Narod, S. A., Sun, P., and Risch, H. A. Ovarian cancer, oral contraceptives, and BRCA mutations. N. Engl. J. Med., 345: 1706-1707, 2001.
13. Phelan, C. M., Rebbeck, T. R., Weber, B. L., Devilee, P., Ruttledge, M. H., Lynch, H. T., Lenoir, G. M., Stratton, M. R., Easton, D. F., Ponder, B. A., Cannon-Albright, L., Larsson, C., Goldgar, D. E., and Narod, S. A. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat. Genet., 12: 309-311, 1996.
14. Runnebaum, I. B., Wang-Gohrke, S., Vesprini, D., Kreienberg, R., Lynch, H., Moslehi, R., Ghadirian, P., Weber, B., Godwin, A. K., Risch, H., Garber, J., Lerman, C., Olopade, O. I., Foulkes, W. D., Karlan, B., Warner, E., Rosen, B., Rebbeck, T., Tonin, P., Dube, M. P., Kieback, D. G., and Narod, S. A. Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics, 11: 635-638, 2001.
15. Rebbeck, T. R., Kantoff, P. W., Krithivas, K., Neuhausen, S., Blackwood, M. A., Godwin, A. K., Daly, M. B., Narod, S. A., Garber, J. E., Lynch, H. T., Weber, B. L., and Brown, M. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J. Hum. Genet., 64: 1371-1377, 1999.
16. Rebbeck, T. R., Wang, Y., Kantoff, P. W., Krithivas, K., Neuhausen, S. L., Godwin, A. K., Daly, M. B., Narod, S. A., Brunet, J. S., Vesprini, D., Garber, J. E., Lynch, H. T., Weber, B. L., and Brown, M. Modification of BRCA1- and BRCA2-associated breast cancer risk by A1B1 genotype and reproductive history. Cancer Res., 61: 5420-5424, 2001.
17. Kadouri, L., Easton, D. F., Edwards, S., Hubert, A., Kote-Jarai, Z., Glaser, B., Durocher, F., Abeliovich, D., Peretz, T., and Eeles, R. A. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. Br. J. Cancer, 85: 36-40, 2001.
18. Venkitaraman, A. R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell, 108: 171-182, 2002.
19. Foray, N., Randrianarison, V., Marot, D., Perricaudet, M., Lenoir, G., and Feunteun, J. γ-Rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene, 18: 7334-7342, 1999.
20. Rothfuss, A., Schutz, P., Bochum, S., Volm, T., Eberhardt, E., Kreienberg, R., Vogel, W., and Speit, G. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res., 60: 390-394, 2000.
21. Buchholz, T. A., Wu, X., Hussain, A., Tucker, S. L., Mills, G. B., Haffty, B., Bergh, S., Story, M., Geara, F. B., and Brock, W. A. Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2. Int. J. Cancer, 97: 557-561, 2002.
22. Baldeyron, C., Jacquemin, E., Smith, J., Jacquemont, C., De Oliveira, I., Gad, S., Feunteun, J., Stoppa-Lyonnet, D., and Papadopoulo, D. A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining. Oncogene, 21: 1401-1410, 2002.
23. Stoppa-Lyonnet, D., Laurent-Puig, P., Essioux, L., Pages, S., Ithier, G., Ligot, L., Fourquet, A., Salmon, R. J., Clough, K. B., Pouillart, P., Bonaiti-Pellie, C., and Thomas, G. BRCA1 sequence variations in 160 individuals referred to a breast/ ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am. J. Hum. Genet., 60: 1021-1030, 1997.
24. Wagner, T., Stoppa-Lyonnet, D., Fleischmann, E., Muhr, D., Pages, S., Sandberg, T., Caux, V., Moeslinger, R., Langbauer, G., Borg, A., and Oefner, P. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics, 62: 369-376, 1999.
25. Real, F. X., Malats, N., Lesca, G., Porta, M., Chopin, S., Lenoir, G. M., and Sinilnikova, O. M. Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer. Gut, 50: 653-657, 2002.
26. Durocher, F., Shattuck-Eidens, D., McClure, M., Labrie, F., Skolnick, M. H., Goldgar, D. E., and Simard, J. Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum. Mol. Genet., 5: 835-842, 1996.
27. Dunning, A. M., Chiano, M., Smith, N. R., Dearden, J., Gore, M., Oakes, S., Wilson, C., Stratton, M., Peto, J., Easton, D., Clayton, D., and Ponder, B. A. Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum. Mol. Genet., 6: 285-289, 1997.
28. Thompson, E. A., Deeb, S., Walker, D., and Motulsky, A. G. The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am. J. Hum. Genet., 42: 113-124, 1988.
29. Thompson, D., and Easton, D. Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol. Biomark. Prev., 11: 329-336, 2002.
30. Smith, S. A., Easton, D. F., Evans, D. G., and Ponder, B. A. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat. Genet., 2: 128-131, 1992.
31. Cornelis, R. S., Neuhausen, S. L., Johansson, O., Arason, A., Kelsell, D., Ponder, B. A. J., Tonin, P., Hamann, U., Lindblom, A., Lalle, P., Longy, M., Olàh, E., Scherneck, S., Bignon, Y., Sobol, H., Chang-Claude, J., Larsson, C., Spurr, N., Borg, Å., Barkardottir, R. B., Narod, S., Devilee, P., and the Breast Cancer Linkage Consortium. High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCA1-linked families. The Breast Cancer Linkage Consortium. Genes Chromosomes Cancer, 13: 203-210, 1995.
32. Goggins, M., Hruban, R. H., and Kern, S. E. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am. J. Pathol., 156: 1767-1771, 2000.
33. Gouya, L., Puy, H., Robreau, A. M., Bourgeois, M., Lamoril, J., Da Silva, V., Grandchamp, B., and Deybach, J. C. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nat. Genet., 30: 27-28, 2002.
34. Randon, J., Boulanger, L., Marechal, J., Garbarz, M., Vallier, A., Ribeiro, L., Tamagnini, G., Dhermy, D., and Delaunay, J. A variant of spectrin low-expression allele α-LELY carrying a hereditary elliptocytosis mutation in codon 28. Br. J. Haematol., 88: 534-540, 1994.
35. Wilmotte, R., Harper, S. L., Ursitti, J. A., Marechal, J., Delaunay, J., and Speicher, D. W. The exon 46-encoded sequence is essential for stability of human erythroid α-spectrin and heterodimer formation. Blood, 90: 4188-4196, 1997.
36. Fan, S., Wang, J., Yuan, R., Ma, Y., Meng, Q., Erdos, M. R., Pestell, R. G., Yuan, F., Auborn, K. J., Goldberg, I. D., and Rosen, E. M. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science (Wash. DC), 284: 1354-1356, 1999.
37. Zheng, L., Annab, L. A., Afshari, C. A., Lee, W. H., and Boyer, T. G. BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc. Natl. Acad. Sci. USA, 98: 9587-9592, 2001.
38. Janezic, S. A., Ziogas, A., Krumroy, L. M., Krasner, M., Plummer, S. J., Cohen, P., Gildea, M., Barker, D., Haile, R., Casey, G., and Anton-Culver, H. Germline BRCA1 alterations in a population-based series of ovarian cancer cases. Hum. Mol. Genet., 8: 889-897, 1999.